MedTrace Logo

A Prospective Trial of the Intelon BOSS(TM) System

NCT04969406 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2022-06-10

No results posted yet for this study

Summary

A prospective, open-label, single-site clinical trial designed to evaluate the repeatability and reproducibility of biomechanical imaging by the BOSS device. Subjects will undergo unilateral biomechanical mapping of the cornea and lens by three BOSS devices operated by three (3) different operators.

Conditions

  • Cornea
  • Lens Diseases

Interventions

OTHER

Brillouin Spectroscopy via BOSS System

Biomechanical Imaging of the Cornea and Lens

Sponsors & Collaborators

  • Intelon Optics, Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-24
Primary Completion
2021-12-10
Completion
2021-12-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969406 on ClinicalTrials.gov